Novartis has acquired a priority review voucher from Pharming for the bargain price of $21.1 million, thanks to some shrewd dealmaking dating back a few years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,